Staar Surgical reported $29.21M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Atrion ATRI:US 8.01M 1.09M
Boston Scientific BSX:US $ 1.06B 93M
Cerus CERS:US $ 20.74M 1.27M
Exact Sciences EXAS:US $ 401.95M 61.72M
Hologic HOLX:US $ 271.9M 6.6M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Meridian Bioscience VIVO:US $ 26.07M 3.67M
Merit Medical Systems MMSI:US $ 84.02M 7.39M
Novartis NOVN:VX 3.5B 486M
Orasure Technologies OSUR:US $ 31.87M 4.31M
Orthofix International OFIX:US $ 73.46M 1.9M
Sientra SIEN:US 25.8M 3.24M
Staar Surgical STAA:US $ 29.21M 674K
Utah Medical Products UTMD:US 2.85M 81K
Valeant Pharmaceuticals VRX:CN C$ 622M 58M